Amrize Ltd (AMRZ) Stock Forecast & Price Target

Amrize is supported by an advantaged North American footprint, the largest cement plant network in North America, and exposure to structurally attractive end markets where cement demand exceeds supply, aggregates behave like local monopolies, and roofing benefits from non-discretionary re-roofing demand and a growing repair-and-renewal cycle. The company also has meaningful embedded earnings leverage from vertical integration, rising organic investment, capacity additions such as 100K tons at Midlothian and the Malarkey factory entering 2027, plus a proven capital deployment playbook that includes more than $650M of repurchases through 9/11/26 and acquisitions that are performing above expectations. Although recent results show margin pressure and H1 2026 FCF use of $986M with cash down to $729M, the combination of strong pricing power potential, double-digit earnings growth potential through the cycle, and normalization benefits from easing oil-related cost headwinds supports a constructive long-term outlook.

Amrize is facing a fundamentally fragile earnings profile because its recent revenue growth has not translated into operating leverage, with Q2'26 revenue of $3,494m up 8.6% YoY yet EBITDA of $986m missing consensus, while margin fell to 28.2% and Building Envelope margin collapsed 350 bps to 22.6% amid $75m of oil-driven freight, diesel, and raw-material inflation offset by only $29m of ASPIRE savings. The company’s upbeat H2 and 2027 narrative depends on assumptions that are only partially under management control—elevated inflation easing, price/cost turning favorable, and H2 delivering roughly $1,972m of EBITDA versus H1’s $1,178m—while peers such as CRH, MLM, and VMC have shown they can preserve or expand margins in similar cost conditions, underscoring Amrize’s weaker execution and cost discipline. Although its North American footprint, mega-project exposure, and ASPIRE synergies targeting about $250m through 2028 provide some support, the combination of guidance credibility risk, potential M&A integration missteps, and a cyclical demand backdrop with inflationary and tariff-related pressure leaves the stock vulnerable to sustained margin disappointment.